Login / Signup

Temozolomide post pazopanib treatment failure in patients with advanced sarcoma: A case series.

Manojkumar BupathiJohn L HaysJames L Chen
Published in: PloS one (2017)
In heavily pretreated patients with advanced sarcoma, the addition of temozolomide to pazopanib was found to be tolerable. Future prospective trials are required to deduce whether temozolomide extends the clinical benefit of pazopanib.
Keyphrases
  • newly diagnosed
  • metastatic renal cell carcinoma
  • current status